Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
Vilmorin & Cie, groupe semencier mondial, annonce aujourd’hui la finalisation de la prise de participation de L’IMAD au capital de Limagrain Vegetable Seeds (LVS), le leader mondial du marché des...
-
Schiphol, July 1, 2026 - Aegon today begins a EUR 200 million share buyback that was announced during the Capital Markets Day on December 10, 2025. This share buyback is expected to be completed by...
-
Aedifica’s legal merger by absorption of Cofinimmo was completed today and 9,162,060 new Aedifica shares were issued
-
Press Release Nicox’s NCX 470 New Drug Application Submitted in the United States by Kowa, with Associated €3 million Milestone Payment NCX 470 New Drug Application (NDA) submitted to the U.S. Food...
-
Communiqué de presseNicox : Demande d’autorisation de mise sur le marché de NCX 470 soumise aux Etats-Unis par Kowa, avec un paiement d’étape de 3 millions d’euros associé La demande d’autorisation de...
-
Data support AGAMREE®’s potential use as a treatment across a broad range of chronic inflammatory rare diseases Pratteln, Switzerland, July 1, 2026 – Santhera Pharmaceuticals (SIX: SANN) today notes...
-
Die Daten untermauern das Potenzial von AGAMREE® als Therapie für ein breites Spektrum chronisch-entzündlicher seltener Erkrankungen Pratteln, Schweiz, 1. Juli 2026 – Santhera Pharmaceuticals (SIX:...
-
Acquisition focused on clinical-stage program potravitug, a first-in-class BK polyomavirus monoclonal antibody Totality of evidence from the Phase II SAFE KIDNEY II trial supports initiation of...
-
Acquisition centrée sur le potravitug, un anticorps monoclonal premier de sa classe au stade clinique, ciblant le polyomavirus BKL’ensemble des données issues de l’essai de phase II SAFE KIDNEY II...
-
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF SUCH...